Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To identify drugs that are coming off of patent
— Data analyst, USA
For information on when certain branded drugs expire, and where
— Director of procurement for clinical trials, USA
To do IP due diligence for investment decisions
— Investment manager, South Korea
To obtain drug patent expiration dates for Switzerland
— Patent attorney, Switzerland
To get patent expiration dates for several products
— Industrial pharmacist, India
Generated: May 23, 2017
These international patent data are derived from patent families, based on US drug-patent linkages.
Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5,922,695 | Jul 25, 2017 | Gilead | TRUVADA | emtricitabine; tenofovir disoproxil fumarate | |||||||||||||||||||||||||
| 5,922,695 | Jan 25, 2018 | Gilead Sciences Inc | STRIBILD | cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate | |||||||||||||||||||||||||
| 5,922,695 | Jan 25, 2018 | Gilead Sciences Inc | COMPLERA | emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate | |||||||||||||||||||||||||
| 5,922,695 | Jan 25, 2018 | Gilead | ATRIPLA | efavirenz; emtricitabine; tenofovir disoproxil fumarate | |||||||||||||||||||||||||
| 5,922,695 | Jan 25, 2018 | Gilead | TRUVADA | emtricitabine; tenofovir disoproxil fumarate | |||||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
To determine when a drug loses patent protection in the United States
— Medical consultant, USA
To get information on international drug patents
— Patent agent, USA
To search for the patent status of products that i will develop
— Business development executive, Indonesia
To analyze generic candidates using patent expiration data
— Portfolio management, Indonesia
To study exclusivity periods for a number of drugs
— Pharmaceutical company, Canada
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
